|
This ends a drawn out legal battle brought by Genevant and Arbutus against Moderna under a week before the jury trial was set to begin.
|
 |
|
The approval was supported by data from the ongoing Phase III MajesTEC-3 study.
|
|
|
The intellectual property will enhance Liberate Bio’s LNP platform for selective programming of monocytes and macrophages.
|
|
|
Experts agree that combination approaches, which may or may not include chemotherapy, will drive improved patient outcomes in oncology.
|
|
|
By blocking the JAK and ROCK pathways, rovadicitinib offers a differentiated mechanism of action to best-selling, single-target GVHD drugs like Jakavi and Imbruvica.
|
|
